TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding TC BioPharm (Holdings) plc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 4 | 5 | +1 |
| Shares | 76.9K | 32.8K | −44.1K (−57.3%) |
| Value | $243.8K | $42.6K | −$201.2K (−82.5%) |
New holders (4)
Institutions that held TC BioPharm (Holdings) plc at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 17,870 | $23.0K | 0.00% |
| Csenge Advisory Group | 14,500 | $19.0K | 0.00% |
| UBS Group AG | 293 | $384 | 0.00% |
| Headlands Technologies LLC | 98 | $128 | 0.00% |
Sold out (3)
Institutions that held TC BioPharm (Holdings) plc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Armistice Capital, LLC | 74,000 | $234.6K |
| Tower Research Capital LLC (TRC) | 2,770 | $8.78K |
| JPMorgan Chase & Co | 89 | $282 |